Outcomes
gonorrhea, chlamydia
SECONDARY, GONORRHEA
The primary outcome was the uptake of dual chlamydia and gonorrhea testing immediately after the intervention, measured during the study visit. The secondary outcome was the cost per person tested and the incremental cost-effectiveness ratio (ICER) between the 2 study arms. We calculated the financial and economic costs from a health care provider perspective, including direct medical expenses related to testing and personnel time. Costs are presented in US dollars (at 2021 exchange rates). We calculated the cost per person tested by dividing each arm’s total cost by the number of FSWs tested. The ICER was also calculated as the incremental cost of the intervention arm compared to the control arm divided by the incremental effectiveness (per person tested).